Biostage

(OTC: BSTG)
Healthcare  |  Biotechnology
2.51 2.2832 1006.26%
Stock Price | July 2, 2020, 3:46 p.m.
0 Followers
Bid: 2.26
Ask: 3.0
Prev. Close: 0.2269
52 Week Low: 2.5
52 Week High: 4.85
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Biostage Inc is a biotechnology company which is developing engineered organ implants based on novel Cellframe technology. The Cellframe technology platform is being developed to treat life-threatening conditions of the esophagus, bronchus, and trachea. Its platform technology provides surgeons a new paradigm to address life-threatening conditions of the esophagus, bronchus, and trachea due to cancer, infection, trauma or congenital abnormalities.

Read more Read less

Recently Viewed Tickers

Premium Stock Watchlist 09/02/2016

3 years ago

Free Stock Watchlist 06/23/2016

4 years ago